Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Non-cash Items (2016 - 2018)

Amicus Therapeutics (FOLD) has disclosed Non-cash Items for 7 consecutive years, with $374444.0 as the latest value for Q1 2018.

  • For the quarter ending Q1 2018, Non-cash Items fell 53.36% year-over-year to $374444.0, compared with a TTM value of $374444.0 through Mar 2018, down 53.36%, and an annual FY2017 reading of $105.8 million, up 2419.05% over the prior year.
  • Non-cash Items was $374444.0 for Q1 2018 at Amicus Therapeutics, down from $105.8 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $105.8 million in Q4 2017 and bottomed at $24900.0 in Q3 2016.
  • Average Non-cash Items over 5 years is $10.7 million, with a median of $3.2 million recorded in 2014.
  • Peak annual rise in Non-cash Items hit 7811.78% in 2016, while the deepest fall reached 99.77% in 2016.
  • Year by year, Non-cash Items stood at $5.4 million in 2014, then plummeted by 98.5% to $81900.0 in 2015, then surged by 5028.21% to $4.2 million in 2016, then surged by 2419.05% to $105.8 million in 2017, then tumbled by 99.65% to $374444.0 in 2018.
  • Business Quant data shows Non-cash Items for FOLD at $374444.0 in Q1 2018, $105.8 million in Q4 2017, and $129500.0 in Q3 2017.